EMAIL US: customerservice@franklinyoung.com
CALL US: (618) 724-2780 / (909) 931-5012
CALL US: (618) 724-2780 / (909) 931-5012
Back to Previous Page
ITEM#: 3042-SCC101
MFR#: SCC101
Estrogen receptor-positive breast cancer is the most common type of breast cancer. About 80% of all breast cancers express the estrogen receptor (ER+) and depend on estrogen to support the growth and spread of the cancer cells. Hormonal therapy, such
| Product Name | Description | Item# | QTY | |
|---|---|---|---|---|
MCF-7/S0.5 Human Breast Cancer Cell Line MCF-7/S0.5 is a tamoxifen-sensitive cell line established from the MCF-7 human breast cancer cell line by adaption to growth in low serum conditions.
|
Estrogen receptor-positive breast cancer is the most common type of breast cancer. About 80% of all breast cancers express the estrogen receptor (ER+) and depend on estrogen to support the growth and spread of the cancer cells. Hormonal therapy, such | 3042-SCC100 | EA | |
UFH-001 Human Breast Cancer Cell Line
|
Triple negative breast cancer (TNBC) accounts for 15-20% of breast cancer cases and is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human EGF receptor 2 (HER2) . TNBC is typically more aggressive and difficu | 3042-SCC210 | EA | |
PMC42-LA Human Breast Cancer Cell Line PMC42-LA human breast cancer cell line is a mammary epithelial cell model that can be used to study epithelial to mesenchymal transition.
|
PMC42-LA is a stable epithelial variant of the mesenchyme-like parental PMC42 /PMC42-ET cell line. PMC42-LA congregate into pavement epithelial sheets at high density, in which the cell-cell borders contain E-cadherin and -catenin, albeit 5-10% of ce | 3042-SCC139 | EA | |
MCF-7 WHOLE CELL LYSATE
|
MCF-7 WHOLE CELL LYSATE - GTX23871 | 3384-GTX23871 | EA | |
MCF-7 Cell Nuclear Extract 200ug
|
MCF-7 Cell Nuclear Extract 200ug | 2976-W09001A85 | EA |